Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-23 · accession 0001708138-22-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-02-24 | 2022-02-23 | REGN | BROWN MICHAEL S | Dir | S - Sale | $608.68 | -500 | 7,162 | -7% | -$304.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | S | D | 500 | $608.68 | 7,162 | I by Trust | — | — |